Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment

Targeted radionuclide therapy (TRT) and immunotherapy are rapidly growing classes of cancer treatments. Basic, translational, and clinical research are now investigating therapeutic combinations of these agents. In comparison to external beam radiation therapy (EBRT), TRT has the unique advantage of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Caroline P., Grudzinski, Joseph J., Nguyen, Thanh Phuong, Hernandez, Reinier, Weichert, Jamey P., Morris, Zachary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865370/
https://www.ncbi.nlm.nih.gov/pubmed/36678756
http://dx.doi.org/10.3390/pharmaceutics15010128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865370/
https://www.ncbi.nlm.nih.gov/pubmed/36678756
http://dx.doi.org/10.3390/pharmaceutics15010128

Ejemplares similares